Draig Therapeutics
Cardiff, Wales, United Kingdom · Biotechnology, Health Care, research
Draig Therapeutics is a clinical-stage company focused on transforming the treatment of neuropsychiatric diseases through its innovative pipeline of next-generation therapies. The company targets core neurotransmission pathways that play a critical role in these complex disorders. Its lead candidate, DT-101, aims to provide more effective treatments for Major Depressive Disorder. Draig was formed
Key facts
- Headquarters
- Cardiff, Wales, United Kingdom
- Employees
- 29
- Industries
- Biotechnology, Health Care, research
- Status
- Private
- Website
- draigtherapeutics.com
- Company page
Recent activity at Draig Therapeutics
Draig Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Series B | $65.0M |
Leadership
- Ivana Magovčević-Liebisch, Chief Executive Officer
Verified email and direct lines for Draig Therapeutics’s decision-makers are on Fundz. See plans
Employee benefit plans
Draig Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Draig Therapeutics in the news
Companies similar to Draig Therapeutics
- BioLineRx Ltd · Biotechnology, Health Care, research, Therapeutics
- Brainstorm Cell Therapeutics · Biotechnology, Health Care, research, Therapeutics
- Nuvig Therapeutics · Biotechnology, Health Care, research, Therapeutics
- Aptose Biosciences · Biotechnology, Health Care, research, Therapeutics
- Corner Therapeutics · Biotechnology, Health Care, research, Therapeutics
About Draig Therapeutics: questions and answers
What does Draig Therapeutics do?
Draig Therapeutics is a clinical-stage company focused on transforming the treatment of neuropsychiatric diseases through its innovative pipeline of next-generation therapies. The company targets core neurotransmission pathways that play a critical role in these complex disorders. Its lead candidate, DT-101, aims to provide more effective treatments for Major Depressive Disorder. Draig was formed
Where is Draig Therapeutics headquartered?
Draig Therapeutics is headquartered in Cardiff, Wales, United Kingdom.
How many employees does Draig Therapeutics have?
Draig Therapeutics has about 29 employees.
Has Draig Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Draig Therapeutics. The most recent, Series B of $65.0M, was in Jul 2026.
Who leads Draig Therapeutics?
Ivana Magovčević-Liebisch is a Chief Executive Officer at Draig Therapeutics.
What is the latest news on Draig Therapeutics?
On Jul 14, 2026, Draig Therapeutics closes an oversubscribed $65 million Series B round led by Deep Track Capital to accelerate the development of neuropsychiatric therapies.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy